Not applicableStudy completedNCT01818947What this trial is testingGefitinib Usage and Outcomes in Routine TreatmentWho this might be right forLung Cancer AstraZeneca 157
Not applicableNo Longer AvailableNCT00655252What this trial is testingExpanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor TherapyWho this might be right forMetastatic Renal Cell Cancer Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT01526928What this trial is testingStudy to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) PatientsWho this might be right forLocally Advanced or Metastatic Non Small Cell Lung Cancer Clovis Oncology, Inc. 612
Large-scale testing (Phase 3)Study completedNCT00125164What this trial is testingPrepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) DeficiencyWho this might be right forGrowth DisordersInsulin-Like Growth Factor-1 Deficiency Ipsen 137
Not applicableStudy completedNCT03106298What this trial is testingIron Deficiency and FGF23 Regulation in CKD and HFWho this might be right forChronic Kidney DiseasesChronic Heart FailureIron Deficiency Anemia Northwestern University 77
Testing effectiveness (Phase 2)Looking for participantsNCT02491099What this trial is testingA Phase II Evaluation of Afatinib in Patients With Persistent or Recurrent HER2-positive Uterine Serous CarcinomaWho this might be right forHER2/Neu+ Uterine Serous Carcinoma Yale University 50
Not applicableLooking for participantsNCT07249216What this trial is testingIdentification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial SettingWho this might be right forAge Related Macular Degeneration Singapore National Eye Centre 117
Early research (Phase 1)Study completedNCT01475006What this trial is testingAMG 595 First-in-Human in Recurrent GliomasWho this might be right forAdvanced Malignant GliomaAnaplastic AstrocytomasGlioblastoma Multiforme Amgen 32
Post-approval studies (Phase 4)Study completedNCT01027481What this trial is testingRanibizumab in Patients With Branch Retinal Vein OcclusionWho this might be right forRetinal Vein Occlusion Medical University of Vienna 30
Testing effectiveness (Phase 2)UnknownNCT02934828What this trial is testingStudy of Preoperative Chemotherapy for Early Triple Negative or HER2-positive Operable Breast CancerWho this might be right forBreast Cancer Chinese Academy of Medical Sciences 230
Large-scale testing (Phase 3)Active Not RecruitingNCT01933932What this trial is testingAssess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLCWho this might be right forLocally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV AstraZeneca 510
Early research (Phase 1)Study completedNCT02406521What this trial is testingExploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone MetsWho this might be right forMetastatic Renal Cell Carcinoma Dana-Farber Cancer Institute 30
Not applicableWithdrawnNCT00813514What this trial is testingDoes Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?Who this might be right forChoroidal NeoVascularizationAge-Related Macular Degeneration Medical University of Vienna
Testing effectiveness (Phase 2)Study completedNCT03888092What this trial is testingZ650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene AmplificationWho this might be right forEsophageal Squamous Cell Carcinoma Sunshine Lake Pharma Co., Ltd. 81
Large-scale testing (Phase 3)Study completedNCT00388128What this trial is testingCaffeine and Intermittent ClaudicationWho this might be right forIntermittent Claudication University of Aarhus 80
Early research (Phase 1)Study completedNCT01703481What this trial is testingEvaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or LymphomaWho this might be right forTumor or Lymphoma Janssen Research & Development, LLC 188
Early research (Phase 1)Active Not RecruitingNCT04680065What this trial is testingGDNF Gene Therapy for Multiple System AtrophyWho this might be right forMultiple System Atrophy Brain Neurotherapy Bio, Inc. 9
Not applicableStudy completedNCT02623621What this trial is testingSoluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyond Progression in Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Azienda Ospedaliero, Universitaria Pisana 103
Post-approval studies (Phase 4)Study completedNCT01028287What this trial is testingAdrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)Who this might be right forDiabetic NephropathyNephrotic Syndrome Southeast Renal Research Institute 15
Early research (Phase 1)Looking for participantsNCT06625593What this trial is testingA First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor BeOne Medicines 168